Device manufacturer, as written on reports
Allergan: medical device reports filed with FDA
9,443 reports name it as the manufacturer of the device involved, 1996–2026.
- 9,443
- reports naming it as manufacturer
- 0% of all MAUDE reports
- 50
- reports, 12 months to August 2026
- 81 in the 12 months before
- 34.9%
- classified as malfunction
- 62.3% across all reports
- 1%
- classified as death, as reported
- 0.9% across all reports
9,443 medical device reports received by FDA give Allergan as the manufacturer of the device involved, 0% of the MAUDE database, from August 1996 to June 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
50 reports arrived in the 12 months to August 2026, down 38% from 81 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (63.4%), malfunction (34.9%) and death (1%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| Lap-Band Adjustable Gastric Banding System Unk Size | Implant, intragastric for morbid obesity | 1,771 | 0 | 2% |
| Lap-Band Ap Adjustable Gastric Banding System Standard | Implant, intragastric for morbid obesity | 781 | 0 | 0.4% |
| Lap-Band Adjustable Gastric Banding System 10 0cm | Implant, intragastric for morbid obesity | 416 | 0 | 0.4% |
| Lap-Band Ap Adjustable Gastric Banding System Small | Implant, intragastric for morbid obesity | 412 | 0 | 1.1% |
| Lap-Band Ap Adjustable Gastric Banding System Large | Implant, intragastric for morbid obesity | 409 | 0 | 1.1% |
| Lap-Band Adjustable Gastric Banding System Vg | Implant, intragastric for morbid obesity | 210 | 0 | 0.8% |
| Lap-Band Adjustable Gastric Banding System 9 75cm | Implant, intragastric for morbid obesity | 201 | 0 | 0.1% |
| Juvederm Ultra Plus Xc Tsk Us | Implant, dermal, for aesthetic use | 140 | 5 | 0% |
| Juvederm Ultra Xc Tsk Us | Implant, dermal, for aesthetic use | 103 | 1 | 0% |
| Juvederm Voluma XC 27G 2 x 1mL | Implant, dermal, for aesthetic use | 91 | 78 | 0% |
| Breast Implant | Prosthesis, breast, noninflatable, internal, silicone gel-filled | 76 | 97 | 1.3% |
| Breast Implants | Prosthesis, breast, noninflatable, internal, silicone gel-filled | 71 | 20 | 1.1% |
| Juvederm VOLUMA WITH LIDOCAINE 1mL | Implant, dermal, for aesthetic use | 69 | 23 | 0% |
| Juvederm Voluma With Lidocaine 1ml Sku1 | Implant, dermal, for aesthetic use | 63 | 0 | 0% |
| UNK Mammary Implant | Prosthesis, breast, inflatable, internal, saline | 44 | 1,887 | 0.2% |
| Style 410 Cohesive Silicone Gel Filled Breast Implant | Prosthesis, breast, noninflatable, internal, silicone gel-filled | 43 | 1,841 | 0.1% |
| Juvederm Voluma Xc/Lido Volume Unknown | Implant, dermal, for aesthetic use | 37 | 194 | 0.1% |
| Style 20 Silicone Gel Filled Breast Implant | Prosthesis, breast, noninflatable, internal, silicone gel-filled | 28 | 981 | 0.1% |
| Silicone Breast Implants | Prosthesis, breast, noninflatable, internal, silicone gel-filled | 24 | 2 | 0% |
| Style 15 Silicone Gel Filled Breast Implant | Prosthesis, breast, noninflatable, internal, silicone gel-filled | 24 | 1,529 | 0.1% |
| Style 68 Saline Filled Breast Implant | Prosthesis, breast, inflatable, internal, saline | 17 | 3,064 | 0% |
| UNK Gel Breast Implant | Prosthesis, breast, noninflatable, internal, silicone gel-filled | 17 | 782 | 0.4% |
| Allergan Cup | Accessories, solution, ultrasonic cleaners for lenses | 14 | 0 | 0% |
| Mcghan | Prosthesis, breast, inflatable, internal, saline | 12 | 0 | 0% |
| Saline Breast Implants | Prosthesis, breast, inflatable, internal, saline | 11 | 2 | 0% |
| Silicone Breast Implant | Prosthesis, breast, noninflatable, internal, silicone gel-filled | 11 | 5 | 0.4% |
| Style 168 Saline Filled Breast Implant | Prosthesis, breast, inflatable, internal, saline | 10 | 318 | 0.1% |
| Juvederm Ultra Xc 1 Ml Coc | Implant, dermal, for aesthetic use | 8 | 0 | 0% |
| Juvederm Ultra/24hv Volume Unknown | Implant, dermal, for aesthetic use | 8 | 9 | 0% |
| Style 120 Silicone Gel Filled Breast Implant | Prosthesis, breast, noninflatable, internal, silicone gel-filled | 6 | 212 | 0.1% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
| Product code | Device type | Reports | Share |
|---|---|---|---|
| LTI | Implant, intragastric for morbid obesity | 5,136 | 54.4% |
| FTR | Prosthesis, breast, noninflatable, internal, silicone gel-filled | 2,486 | 26.3% |
| LMH | Implant, dermal, for aesthetic use | 1,540 | 16.3% |
| FWM | Prosthesis, breast, inflatable, internal, saline | 767 | 8.1% |
| OXF | Mesh, surgical, absorbable, plastic and reconstructive surgery | 200 | 2.1% |
| HQC | Unit, phacofragmentation | 121 | 1.3% |
| LCJ | Tissue expander and accessories | 113 | 1.2% |
| HQL | Intraocular lens | 92 | 1% |
| LPN | Accessories, soft lens products | 74 | 0.8% |
| MFK | Lens, multifocal intraocular | 42 | 0.4% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Allergan reports
How many FDA device reports name Allergan as manufacturer?
9,443 reports through August 2026, 50 of them in the latest 12 months.
Which of its brands appear most often?
Lap-Band Adjustable Gastric Banding System Unk Size (1,771), Lap-Band Ap Adjustable Gastric Banding System Standard (781), Lap-Band Adjustable Gastric Banding System 10 0cm (416), Lap-Band Ap Adjustable Gastric Banding System Small (412) and Lap-Band Ap Adjustable Gastric Banding System Large (409).
Which device types does it report on?
implant, intragastric for morbid obesity (54.4%), prosthesis, breast, noninflatable, internal, silicone gel-filled (26.3%), implant, dermal, for aesthetic use (16.3%) and prosthesis, breast, inflatable, internal, saline (8.1%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.